EuroAPI Header EuroAPI Header

X

(5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone manufacturers and suppliers on PharmaCompass

PharmaCompass
(5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone
Also known as: 915095-85-1, (5-bromo-2-chlorophenyl)-(4-fluorophenyl)methanone, Schembl2637828, Amy39947, Mfcd12410140, Zinc34775740
Molecular Formula
C13H7BrClFO
Molecular Weight
313.55  g/mol
InChI Key
LVILQFKAGQFQEK-UHFFFAOYSA-N

1 2D Structure

(5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5-bromo-2-chlorophenyl)-(4-fluorophenyl)methanone
2.1.2 InChI
InChI=1S/C13H7BrClFO/c14-9-3-6-12(15)11(7-9)13(17)8-1-4-10(16)5-2-8/h1-7H
2.1.3 InChI Key
LVILQFKAGQFQEK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1C(=O)C2=C(C=CC(=C2)Br)Cl)F
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 915095-85-1

2. (5-bromo-2-chlorophenyl)-(4-fluorophenyl)methanone

3. Schembl2637828

4. Amy39947

5. Mfcd12410140

6. Zinc34775740

7. Akos005831751

8. Bs-17834

9. Db-120590

10. Cs-0162265

11. D84028

12. (5-bromo-2-chlorophenyl)(4-fluorophenyl) Methanone

13. Methanone, (5-bromo-2-chlorophenyl)(4-fluorophenyl)-

2.3 Create Date
2007-02-21
3 Chemical and Physical Properties
Molecular Weight 313.55 g/mol
Molecular Formula C13H7BrClFO
XLogP34.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass311.93528 g/mol
Monoisotopic Mass311.93528 g/mol
Topological Polar Surface Area17.1 Ų
Heavy Atom Count17
Formal Charge0
Complexity279
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
86087-24-3
Empagliflozin
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
90866-33-4
Empagliflozin
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
86087-23-2
Empagliflozin
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
86728-85-0
Empagliflozin
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY